Sepsis, oxidative stress, and hypoxia: Are there clues to better treatment?

Redox Report

Volumn 20, Issue 5, 2015, Pages 193-197

  Bar Or, David ^a,b,c   Carrick, Matthew M ^b   Mains, Charles W ^c   Rael, Leonard T ^a,b,c   Slone, Denetta ^a   Brody, Edward N ^d  

^a SWEDISH MEDICAL CENTER   (United States)

^b Medical Center of Plano   (United States)

^c ST ANTHONY HOSPITAL   (United States)

^d SomaLogic Inc   (United States)

Author keywords

Electron transport chain; Inflammation; Ischemia; Mitochondria; Oxidative stress; Reperfusion; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

ADENOSINE TRIPHOSPHATE; FREE RADICAL; FUMARIC ACID; OXYGEN; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUCCINIC ACID; SUPEROXIDE;

ARTICLE; ELECTRON TRANSPORT; HUMAN; HYPOXEMIA; HYPOXIA; ISCHEMIA; MESSENGER RNA SYNTHESIS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN THERAPY; PRIORITY JOURNAL; REPERFUSION; REPERFUSION INJURY; RESPIRATORY BURST; RESPIRATORY CHAIN; SEPSIS; ANOXIA; METABOLISM; PHYSIOLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANOXIA; ELECTRON TRANSPORT; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84940023160     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000215Y.0000000005     Document Type: Article

References (29)

1. 1 Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc 2013;88(10):1127-40.
2. Dolgin E. Trial failure prompts soul-searching for critical-care specialists. Nat Med 2012;18(7):1000.
3. Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med 2014;20(4):195-203.
4. Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007;35(12): 2762-8.
5. Ji H, Rabbi MF, Labis B, Pavlov VA, Tracey KJ, Ghia JE. Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis. Mucosal Immunol 2014;7(2): 335-47.
6. Koopman FA, Schuurman PR, Vervoordeldonk MJ, Tak PP. Vagus nerve stimulation: a new bioelectronics approach to treat rheumatoid arthritis? Best Pract Res Clin Rheumatol 2014; 28(4):625-35.
7. Bar-Or D, Bar-Or R, Rael LT, Brody EN. Oxidative stress in severe acute illness. Redox Biol 2015;4C:340-5.
8. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000;156(3):965-76.
9. Scholz H, Schurek HJ, Eckardt KU, Bauer C. Role of erythro-poietin in adaptation to hypoxia. Experientia 1990;46(11-12): 1197-201.
10. Staudacher JJ, Naarmann-de Vries IS, Ujvari SJ, Klinger B, Kasim M, Benko E, et al. Hypoxia-induced gene expression results from selective mRNA partitioning to the endoplasmic reticulum. Nucleic Acids Res 2015. doi: 10.1093/nar/gkv167.
11. Ruas JL, Poellinger L. Hypoxia-dependent activation of HIF into a transcriptional regulator. Semin Cell Dev Biol 2005; 16(4-5):514-22.
12. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 2000;275(33):25130-8.
13. Stolze IP, Mole DR, Ratcliffe PJ. Regulation of HIF: prolyl hydroxylases. Novartis Found Symp 2006;272:15-25; discussion-36.
14. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 2006;91(5):807-19.
15. de Jong HK, van der Poll T, Wiersinga WJ. The systemic pro-inflammatory response in sepsis. J Innate Immun 2010;2(5): 422-30.
16. Gomez HG, Gonzalez SM, Londono JM, Hoyos NA, Nino CD, Leon AL, et al. Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*. Crit Care Med 2014;42(4):771-80.
17. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;181(1):176-80.
18. Yassen KA, Galley HF, Lee A, Webster NR. Mitochondrial redox state in the critically ill. Br J Anaesth 1999;83(2):325-7.
19. Brealey D, Singer M. Mitochondrial dysfunction in sepsis. Curr Infect Dis Rep 2003;5(5):365-71.
20. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002;360(9328): 219-23.
21. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32(1):21-30.
22. Su F, Huang H, Akieda K, Occhipinti G, Donadello K, Piagnerelli M, et al. Effects of a selective iNOS inhibitor versus norepinephrine in the treatment of septic shock. Shock 2010;34(3):243-9.
23. Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier S. Y, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 2014; 515(7527):431-5.
24. Luce JM. Pathogenesis and management of septic shock. Chest 1987;91(6):883-8.
25. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 2013; 496(7444):238-42.
26. Andrades ME, Morina A, Spasic S, Spasojevic I. Bench-to-bedside review: sepsis - from the redox point of view. Crit Care 2011;15(5):230.
27. Zhang S, Cheng K, Wang X, Yin H. Selection, synthesis, and anti-inflammatory evaluation of the arylidene malonate derivatives as TLR4 signaling inhibitors. Bioorg Med Chem 2012; 20(20):6073-9.
28. Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 2010;1201:96-103.
29. Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011;107(1):57-64.